ImmunityBio Inc (NASDAQ: IBRX) Has Succeeded In Attracting Investors This Year, The Stock Is Up 4.38% Year-To-Date
ImmunityBio Inc (NASDAQ:IBRX)’s traded shares stood at 4.41 million during the last session, with the company’s beta value hitting 1.19. At the close of trading,